Intravenous Anti-IL-5 Monoclonal Antibody Reduces Eosinophils and Tenascin Deposition in Allergen-Challenged Human Atopic Skin
- 1 June 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 122 (6) , 1406-1412
- https://doi.org/10.1111/j.0022-202x.2004.22619.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effect of SCH55700, a Humanized Anti-Human Interleukin-5 Antibody, in Severe Persistent AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic AirwayAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Airway Subepithelial Fibrosis in a Murine Model of Atopic AsthmaAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Tenascin Is Increased in Airway Basement Membrane of Asthmatics and Decreased by an Inhaled SteroidAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Eosinophils: Biology and Role in DiseasePublished by Elsevier ,1995
- Release of eosinophil granule proteins during IgE-mediated allergic skin reactionsJournal of Allergy and Clinical Immunology, 1991
- Identification of Activated T Lymphocytes and Eosinophils in Bronchial Biopsies in Stable Atopic AsthmaAmerican Review of Respiratory Disease, 1990
- Tenascin: An Extracellular Matrix Protein Prominent in Specialized Embryonic Tissues and TumorsAnnual Review of Cell Biology, 1989
- The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR)Journal of Allergy and Clinical Immunology, 1989
- Localization of eosinophil granule major basic protein in human basophils.The Journal of Experimental Medicine, 1983